Differences in health-related quality of life of prostate cancer patients based on stage of cancer-Reference-Cited by-同舟云学术

Differences in health-related quality of life of prostate cancer patients based on stage of cancer

Published:2004 Issue:11 Volume:13 Page:800-807
ISSN:1057-9249
Container-title:Psycho-Oncology
language:en
Short-container-title:Psycho-Oncology

Author:

Rosenfeld Barry,Roth Andrew J.,Gandhi Sanjay,Penson David

Publisher

Wiley

Subject

Psychiatry and Mental health,Oncology,Experimental and Cognitive Psychology

Reference24 articles.

1. et al. (eds). 1992. Manual for Staging of Cancer (4th edn). American Joint Committee on Cancer, Lippincott: Philadelphia.

2. 1996. The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials, (ed.). Lippon-Raven: Philadelphia;203-214.

3. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

4. Changes in quality of life following treatment for early prostate cancer

5. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty and its association with health-related quality of life among older cancer patients: an evidence-based study from China;Health and Quality of Life Outcomes;2022-08-19

2. A pilot feasibility study of Exercising Together© during radiation therapy for prostate cancer: a dyadic approach for patients and spouses;Pilot and Feasibility Studies;2021-12

3. Preliminary Development of a Mindfulness-Based Group Therapy to Expand Couples’ Sexual Intimacy after Prostate Cancer: A Mixed Methods Approach;Sexual Medicine;2021-04

4. Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration;Supportive Care in Cancer;2020-07-06

5. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study;The Lancet Oncology;2019-03